Fig. 2From: Landscape analysis of available European data sources amenable for machine learning and recommendations on usability for rare diseases screeningDistribution of the databases characteristic by type of the registry (the overall percentage exceeds 100%, because this was a semi-closed enumerated question)Back to article page